Display Settings:

Format

Send to:

Choose Destination
Curr Opin Struct Biol. 2006 Feb;16(1):127-36. Epub 2006 Jan 25.

Can we rationally design promiscuous drugs?

Author information

  • 1Pfizer Global Research and Development, Sandwich, Kent CT13 9NJ, UK. andrew.hopkins@pfizer.com

Abstract

Structure-based drug design is now used widely in modern medicinal chemistry. The application of structural biology to medicinal chemistry has heralded the "rational drug design" vision of discovering exquisitely selective ligands. However, recent advances in post-genomic biology are indicating that polypharmacology may be a necessary trait for the efficacy of many drugs, therefore questioning the "one drug, one target" assumption of current rational drug design. By combining advances in chemoinformatics and structural biology, it might be possible to rationally design the next generation of promiscuous drugs with polypharmacology.

PMID:
16442279
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk